Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMD NYSE:ALUR NASDAQ:MBAI NASDAQ:SURG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$2.09-5.4%$2.25$1.36▼$30.40$3.47M1.491.55 million shs554,832 shsALURAllurion Technologies$0.67-5.6%$0.78$0.23▼$3.33$10.65M-0.181.62 million shs31,274 shsMBAICheck-Cap$1.68+4.8%$1.68$0.59▼$3.92$11.66M0.57180,339 shs44,800 shsSURGSurgePays$0.58-2.5%$0.64$0.46▼$3.45$14.86M0.31155,085 shs82,596 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical+9.05%+9.55%+4.78%+36.16%-91.64%ALURAllurion Technologies-5.63%-19.22%-4.29%-4.54%-75.00%MBAICheck-Cap+6.87%-3.93%+17.93%+0.59%+170,999,900.00%SURGSurgePays+0.69%+18.69%+4.23%-27.11%-78.95%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$2.09-5.4%$2.25$1.36▼$30.40$3.47M1.491.55 million shs554,832 shsALURAllurion Technologies$0.67-5.6%$0.78$0.23▼$3.33$10.65M-0.181.62 million shs31,274 shsMBAICheck-Cap$1.68+4.8%$1.68$0.59▼$3.92$11.66M0.57180,339 shs44,800 shsSURGSurgePays$0.58-2.5%$0.64$0.46▼$3.45$14.86M0.31155,085 shs82,596 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical+9.05%+9.55%+4.78%+36.16%-91.64%ALURAllurion Technologies-5.63%-19.22%-4.29%-4.54%-75.00%MBAICheck-Cap+6.87%-3.93%+17.93%+0.59%+170,999,900.00%SURGSurgePays+0.69%+18.69%+4.23%-27.11%-78.95%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 1.50ReduceN/AN/AALURAllurion Technologies 2.00Hold$3.00347.76% UpsideMBAICheck-Cap 1.00SellN/AN/ASURGSurgePays 1.67Reduce$5.00739.21% UpsideCurrent Analyst Ratings BreakdownLatest AEMD, MBAI, SURG, and ALUR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/22/2026SURGSurgePays Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)5/15/2026SURGSurgePays Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell4/24/2026MBAICheck-Cap Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/20/2026AEMDAethlon Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/17/2026SURGSurgePays Ascendiant Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$9.75 ➝ $5.00(Data available from 6/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon MedicalN/AN/AN/AN/A$25.52 per shareN/AALURAllurion Technologies$17.21M0.58N/AN/A($30.08) per share-0.02MBAICheck-CapN/AN/A$0.61 per share2.82$0.47 per shareN/ASURGSurgePays$56.96M0.26N/AN/A($0.66) per share-0.90Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$13.39M-$14.69N/AN/AN/AN/A-219.39%-164.33%6/25/2026 (Estimated)ALURAllurion Technologies-$7.20M-$1.75N/AN/AN/A-199.96%N/A-77.13%8/18/2026 (Estimated)MBAICheck-Cap$4.14M-$2.77N/AN/AN/AN/AN/AN/AN/ASURGSurgePays-$36.07M-$1.94N/A9.93N/A-64.91%-967.32%-310.16%8/12/2026 (Estimated)Latest AEMD, MBAI, SURG, and ALUR EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/25/2026Q4 2026AEMDAethlon Medical-$2.1656N/AN/AN/AN/AN/A5/20/2026Q4 2025SURGSurgePays-$0.19-$0.51-$0.32-$0.51$15.50 million$15.98 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/AALURAllurion TechnologiesN/AN/AN/AN/AN/AMBAICheck-CapN/AN/AN/AN/AN/ASURGSurgePaysN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A5.685.68ALURAllurion TechnologiesN/A1.260.94MBAICheck-CapN/A0.050.05SURGSurgePaysN/A0.270.26Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%ALURAllurion Technologies21.39%MBAICheck-Cap1.07%SURGSurgePays6.94%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical0.71%ALURAllurion Technologies8.10%MBAICheck-Cap0.48%SURGSurgePays29.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical101.57 million1.56 millionNo DataALURAllurion Technologies50114.99 million11.28 millionNo DataMBAICheck-Cap807.29 million7.25 millionN/ASURGSurgePays4025.12 million17.81 millionOptionableAEMD, MBAI, SURG, and ALUR HeadlinesRecent News About These CompaniesWhy The Narrative Around SurgePays (SURG) Is Shifting After New Risk And Valuation UpdatesJune 1 at 1:15 PM | finance.yahoo.comSurgepays Inc (SURG) Q1 2026 Earnings Call Highlights: Robust Revenue Growth Amid Operational ...May 15, 2026 | finance.yahoo.comSurgePays Delays Quarterly Report Filing BrieflyMay 15, 2026 | tipranks.comSurgePays Reports First Quarter 2026 Revenue of Approximately $16 Million, Up 51% Year-Over-Year Driven by Point of Sale and Prepaid Services Growth of 71%May 15, 2026 | globenewswire.comSurgePays, Inc. Launches 25,000 Activation Pilot to Monetize Subprime Customer Base Through Alpha Cash IntegrationMay 12, 2026 | quiverquant.comQSurgePays Launches Alpha Cash Pilot to Monetize Subprime Consumer Distribution, First in a Planned SeriesMay 12, 2026 | globenewswire.comSurgePays to Host First Quarter 2026 Financial Results Conference Call on May 15thMay 11, 2026 | globenewswire.comHow The SurgePays (SURG) Story Is Shifting As Analysts Rework Valuation AssumptionsMay 3, 2026 | finance.yahoo.comF5 Networks (FFIV) Beats Q2 Earnings and Revenue EstimatesApril 28, 2026 | zacks.comSurgePays Advances AI Decisioning Platform Focused on Increasing Revenue Per User Across the Subprime MarketApril 21, 2026 | globenewswire.comSurgePays, Inc. Q4 2025 Earnings Call SummaryApril 16, 2026 | finance.yahoo.comSurgePays, Inc. (NASDAQ:SURG) Q4 2025 Earnings Call TranscriptApril 16, 2026 | insidermonkey.comSurgePays (SURG) Q4 2025 Earnings Call TranscriptApril 15, 2026 | fool.comSurgePays, Inc.: SurgePays Reports Full Year 2025 Results and Highlights Scalable Growth Model with Improved Cost Structure Entering 2026April 15, 2026 | finanznachrichten.deSurgepays Inc (SURG) Q4 2025 Earnings Call Highlights: Navigating Challenges and Capitalizing ...April 15, 2026 | finance.yahoo.comSurgePays (SURG) stock falls 30% overnight: What's going on?April 15, 2026 | msn.comSurgePays, Inc. (SURG) Q4 2025 Earnings Call TranscriptApril 14, 2026 | seekingalpha.comSurgePays Reports Full Year 2025 Results and Highlights Scalable Growth Model with Improved Cost Structure Entering 2026April 14, 2026 | globenewswire.comSurgePays Delays Filing of Annual 10-K ReportApril 10, 2026 | theglobeandmail.comSurgePays Launches Stored Value and Loyalty Platform Across Retail NetworkApril 2, 2026 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines2 Software Stocks Turning AI Fears Into Fundamental GainsBy Dan Schmidt | May 21, 2026Rocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?By Ryan Hasson | May 12, 2026As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants InBy Leo Miller | May 17, 2026Qualcomm’s 50% Surge: Bubble Territory or Breakout Moment?By Sam Quirke | May 4, 20263 Under-The-Radar Small Caps Making New All-Time HighsBy Dan Schmidt | May 10, 2026AEMD, MBAI, SURG, and ALUR Company DescriptionsAethlon Medical NASDAQ:AEMD$2.09 -0.12 (-5.38%) As of 01:02 PM Eastern This is a fair market value price provided by Massive. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.Allurion Technologies NYSE:ALUR$0.67 -0.04 (-5.63%) As of 06/1/2026 02:47 PM EasternAllurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.Check-Cap NASDAQ:MBAI$1.68 +0.08 (+4.75%) As of 01:02 PM Eastern This is a fair market value price provided by Massive. Learn more.Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.SurgePays NASDAQ:SURG$0.58 -0.01 (-2.48%) As of 01:02 PM Eastern This is a fair market value price provided by Massive. Learn more.SurgePays, Inc., together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities. SurgePays, Inc. is headquartered in Bartlett, Tennessee. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MGM Buyout: The House Doesn't Always Win Alphabet's $80 Billion Offering: Worrisome Dilution or AI Confidence? Eli Lilly Wins Back CVS Health, Reverting Novo's Advantage Palantir’s Drone Tailwind Puts Its Defense AI Story Back in Focus for Investors How the Latest Federal Contract Boosts D-Wave's Prospects 5 Reasons to Pony Up for Pony AI Stock—and 1 Reason to Wait Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance MarketBeat Week in Review – 05/25 - 05/29 Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
